Published in Biophys J on January 03, 2012
Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest (2014) 1.18
Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level. Acta Biomater (2013) 0.93
Submillisecond elastic recoil reveals molecular origins of fibrin fiber mechanics. Biophys J (2013) 0.87
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Blood (2015) 0.85
A modular fibrinogen model that captures the stress-strain behavior of fibrin fibers. Biophys J (2012) 0.85
Elastic behavior and platelet retraction in low- and high-density fibrin gels. Biophys J (2015) 0.84
Fibrin Networks Support Recurring Mechanical Loads by Adapting their Structure across Multiple Scales. Biophys J (2016) 0.81
Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation. Biophys J (2016) 0.77
Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII. Blood (2016) 0.77
Fibrin mechanical properties and their structural origins. Matrix Biol (2016) 0.77
Biophysical Mechanisms Mediating Fibrin Fiber Lysis. Biomed Res Int (2017) 0.75
Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties. Blood Coagul Fibrinolysis (2016) 0.75
Experimental mechanics of magnetic microparticle-induced strain on fibrin clots. J Biomed Mater Res A (2014) 0.75
Fibrin Formation, Structure and Properties. Subcell Biochem (2017) 0.75
Structural origins of fibrin clot rheology. Biophys J (1999) 3.68
The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem (2004) 2.91
The mechanical properties of single fibrin fibers. J Thromb Haemost (2010) 2.63
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol (2006) 2.61
Assembly of fibrin. A light scattering study. J Biol Chem (1979) 2.31
Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water. Science (2009) 2.30
Fibrin fibers have extraordinary extensibility and elasticity. Science (2006) 2.30
Cross-linked gamma-chains in fibrin fibrils bridge 'transversely' between strands: yes. J Thromb Haemost (2004) 2.30
Size and density of fibrin fibers from turbidity. Macromolecules (1978) 2.12
Forced unfolding of coiled-coils in fibrinogen by single-molecule AFM. Biophys J (2006) 1.96
Tensile properties of single stress fibers isolated from cultured vascular smooth muscle cells. J Biomech (2005) 1.95
Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. Biophys J (2004) 1.71
Molecular basis of fibrin clot elasticity. Structure (2008) 1.54
Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J (2010) 1.53
A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem Biophys (2007) 1.48
The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood (2005) 1.46
Structural hierarchy governs fibrin gel mechanics. Biophys J (2010) 1.43
Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry (2007) 1.41
The Mechanism of Polymerization of Fibrinogen. Proc Natl Acad Sci U S A (1952) 1.30
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood (2007) 1.25
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci (2001) 1.21
Flow rate and fibrin fiber alignment. J Thromb Haemost (2010) 1.19
Length of tandem repeats in fibrin's alphaC region correlates with fiber extensibility. J Thromb Haemost (2008) 1.17
Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis. Thromb Haemost (2010) 1.12
Concentration of protein in fibrin fibers and fibrinogen polymers determined by refractive index matching. Biopolymers (1986) 1.10
Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci U S A (1989) 1.10
Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction. Blood Coagul Fibrinolysis (1994) 1.10
Evidence that αC region is origin of low modulus, high extensibility, and strain stiffening in fibrin fibers. Biophys J (2010) 1.09
The mechanical properties of individual, electrospun fibrinogen fibers. Biomaterials (2008) 1.01
Low-frequency ultrasound induces nonenzymatic thrombolysis in vitro. J Ultrasound Med (2002) 1.01
Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. Biophys J (1996) 0.97
Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost (1992) 0.91
Easy and direct method for calibrating atomic force microscopy lateral force measurements. Rev Sci Instrum (2007) 0.90
Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release. J Biol Chem (2000) 0.89
Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A. Biochemistry (1993) 0.82
Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization. J Thromb Haemost (2003) 0.82
Alpha-Chain cross-linking in fibrin(ogen) Marburg. Blood (1995) 0.79
Fibrinogen Marburg a new genetic variant of fibrinogen. Blut (1977) 0.78
Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol (2011) 1.59
Interactions between factor XIII and the alphaC region of fibrinogen. Blood (2011) 1.58
Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication. J Vasc Surg (2008) 1.43
The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain. Blood (2013) 1.42
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood (2003) 1.29
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood (2007) 1.25
The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood (2009) 1.25
Interconvertible lac repressor-DNA loops revealed by single-molecule experiments. PLoS Biol (2008) 1.23
Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood (2010) 1.23
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation (2003) 1.17
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol (2004) 1.17
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood (2011) 1.15
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation (2002) 1.13
Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano (2009) 1.12
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet (2003) 1.10
Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano (2010) 1.06
A combined atomic force/fluorescence microscopy technique to select aptamers in a single cycle from a small pool of random oligonucleotides. Microsc Res Tech (2007) 1.01
The mechanical properties of individual, electrospun fibrinogen fibers. Biomaterials (2008) 1.01
Markers of inflammation in men with small abdominal aortic aneurysm. J Vasc Surg (2010) 1.01
A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet (2013) 1.00
The molecular physiology and pathology of fibrin structure/function. Blood Rev (2005) 1.00
Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity. Blood (2007) 0.99
Substrates of Factor XIII-A: roles in thrombosis and wound healing. Clin Sci (Lond) (2013) 0.96
Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost (2007) 0.95
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol (2002) 0.93
Easy and direct method for calibrating atomic force microscopy lateral force measurements. Rev Sci Instrum (2007) 0.90
Developing a problem-based learning (PBL) curriculum for professionalism and scientific integrity training for biomedical graduate students. J Med Ethics (2010) 0.90
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diab Vasc Dis Res (2012) 0.90
Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion. Blood (2010) 0.90
The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice. J Thromb Haemost (2014) 0.88
Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness. J Thromb Haemost (2012) 0.87
The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes (2002) 0.86
Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2002) 0.86
A modular fibrinogen model that captures the stress-strain behavior of fibrin fibers. Biophys J (2012) 0.85
Role of fibrin structure in thrombosis and vascular disease. Adv Protein Chem Struct Biol (2011) 0.85
Characterizing the micro-scale elastic modulus of hydrogels for use in regenerative medicine. J Mech Behav Biomed Mater (2013) 0.84
Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood (2002) 0.84
Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm. J Vasc Surg (2013) 0.83
Multiscale modeling of double-helical DNA and RNA: a unification through Lie groups. J Phys Chem B (2012) 0.83
Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers. Biophys J (2009) 0.83
Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size. Arterioscler Thromb Vasc Biol (2011) 0.82
Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes. Diabetes Care (2012) 0.82
Alteration of fibrin clot properties by ultrafine particulate matter. Thromb Haemost (2009) 0.82
The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. Twin Res (2003) 0.81
Combining capillary electrophoresis and next-generation sequencing for aptamer selection. Anal Bioanal Chem (2015) 0.81
Single DNA molecule analysis of transcription complexes. Methods Enzymol (2003) 0.80
Fibrinogen and fibrin clot structure in diabetes. Herz (2004) 0.80
Binding of carboxypeptidase N to fibrinogen and fibrin. Biochem Biophys Res Commun (2012) 0.79
Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans. Blood (2013) 0.79
Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus. Arterioscler Thromb Vasc Biol (2006) 0.79
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity. Blood (2013) 0.79
Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men. Br J Haematol (2002) 0.78
PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE. Nano Life (2013) 0.78
The Mechanical Properties of Dry, Electrospun Fibrinogen Fibers. Mater Sci Eng C Mater Biol Appl (2011) 0.78
Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication". J Vasc Surg (2009) 0.77
PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA. Cell Biochem Biophys (2013) 0.77
Denaturing of single electrospun fibrinogen fibers studied by deep ultraviolet fluorescence microscopy. Microsc Res Tech (2011) 0.75
Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation. Br J Haematol (2012) 0.75
Selection of bead-displayed, PNA-encoded chemicals. J Mol Recognit (2010) 0.75
Role of proteomic technologies in understanding risk of arterial thrombosis. Expert Rev Proteomics (2009) 0.75
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction. Blood (2011) 0.75
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes. Thromb Haemost (2016) 0.75